University of Arkansas: New Nano Drug Candidate Kills Aggressive Breast Cancer Cells
July 21, 2020
July 21, 2020
FAYETTEVILLE, Arkansas, July 21 -- The University of Arkansas issued the following news:
Researchers at the University of Arkansas have developed a new nano drug candidate that kills triple negative breast cancer cells.
Triple negative breast cancer is one of the most aggressive and fatal types of breast cancer. The research will help clinicians target breast cancer cells directly, while avoiding the adverse, toxic side effects of chemotherapy.
Their study . . .
Researchers at the University of Arkansas have developed a new nano drug candidate that kills triple negative breast cancer cells.
Triple negative breast cancer is one of the most aggressive and fatal types of breast cancer. The research will help clinicians target breast cancer cells directly, while avoiding the adverse, toxic side effects of chemotherapy.
Their study . . .